Research News and Research

RSS

Soligenix reports Phase 2 clinical trial results of orBec for GVHD

Soligenix, Inc. a late-stage biopharmaceutical company, today reported preliminary results from its Phase 2 "proof-of-concept" exploratory clinical trial of orBec for the prevention of acute Graft-versus-Host disease (GVHD) in patients undergoing myeloablative conditioning regimens with initiation of dosing prior to hematopoietic cell transplantation (HCT) and continuing through the post-transplantation period.

25 Oct 2010

DATATRAK announces 2010 Q4 release of eClinical solution

DATATRAK International, Inc. a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the 2010 Q4 release of its DATATRAK eClinical solution.

25 Oct 2010

Competition for agricultural land contributes to hunger of 500M small-scale farmers, U.N. official says

Approximately 500 million small-scale farmers worldwide are going hungry because of "an explosive cocktail" of farmland speculation, environmental damages and urbanization, Olivier De Schutter, the U.N. special rapporteur on the right to food, said on Thursday, the Associated Press/Winnipeg Free Press reports (Lederer, 10/21).

25 Oct 2010

Barriers for female heart patients entering cardiac rehab

Cardiac rehabilitation is considered the pillar of preventing a second cardiac event yet those who stand to benefit the most - women and the elderly − are often missing out, Dr. Billie Jean Martin told the Canadian Cardiovascular Congress 2010, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

25 Oct 2010

Cryo-Cell to launch new reproductive tissue service for cryopreserved embryos, oocyctes

Cryo-Cell International, Inc. one of the world's largest and most established family cord blood banks and global stem cell innovators, today announced plans at the annual meeting of the American Society of Reproductive Medicine (ASRM) to launch Cryology RTS, a new reproductive tissue storage service for cryopreserved embryos, oocyctes and sperm.

25 Oct 2010

First Edition: October 25, 2010

Today's headlines include the latest on health overhaul policies and politics as the mid-term election grows closer.

25 Oct 2010

Non communicable diseases will cost India USD237 billion during 2006-15

Health experts participating at a roundtable organised by India Health Progress(IHP) on economic and social impact of non-communicable diseases in India are of the opinion that a concerted effort is required to address the growing burden.

25 Oct 2010

Popular Mechanics recognizes three NSF-funded projects with innovation Breakthrough Awards

Popular Mechanics has recognized three NSF-funded projects with innovation Breakthrough Awards: an artificial retina returning sight to those who have lost it; a system that uses "controlled rocking" and energy-dissipating fuses to help buildings withstand earthquakes; and an inexpensive medical microscope built for cell-phones that allows doctors in rural villages to identify malaria-infected blood cells.

25 Oct 2010

New report highlights numerous monoclonal antibodies for treating digestive system cancers

Since the early development of monoclonal antibodies (mAbs), almost forty years ago, twenty-four therapeutic mAbs have been approved, four of them targeting digestive system cancers. Due to this success (two blockbusters reaching sales of over $1 billion), many industrials position themselves on this very attractive sector.

25 Oct 2010

Childhood allergies and asthma linked to development in the womb

A child's chances of developing allergies or wheezing is related to how he or she grew at vital stages in the womb, according to scientists from the University of Southampton.

25 Oct 2010

New Canadian Cardiovascular Society guidelines support clinicians in practicing evidence-based medicine

Summaries of a number of new Canadian Cardiovascular Society guidelines and position statements offering the most up to date information to support clinicians in practicing evidence-based medicine were released at the Canadian Cardiovascular Congress 2010 this week.

25 Oct 2010

Antigenics expands HSPPC-96 Phase 2 clinical study in glioma

Antigenics, Inc. today announced the expansion of a phase 2 clinical study of HSPPC-96 (Oncophage® vaccine; vitespen), Antigenics' personalized therapeutic cancer vaccine, in patients with newly diagnosed glioma.

25 Oct 2010

Neptune launches Onemia medical food

Neptune Technologies & Bioressources Inc. enters the pharmaceutical market with the launch of Onemia™, the first medical food of Neptune's subsidiary Acasti Pharma Inc.. Only two years since its foundation, Acasti has completed the development and launch of "Onemia™" on October 21, 2010 at the Cardiometabolic Health Congress meeting in Boston.

25 Oct 2010

Diabetics living in adverse neighborhood conditions more likely to develop lower body functional limitations

A study published earlier this year in the peer reviewed online journal BMC Public Health has found that residing in a neighborhood with adverse living conditions such as low air quality, loud traffic or industrial noise, or poorly maintained streets, sidewalks and yards, makes mobility problems much more likely in late middle-aged African Americans with diabetes.

25 Oct 2010

Researchers publish effects of doctor-designed formula against breast cancer

Researchers at Indiana University and Methodist Research Institute have published the dramatic effects of a natural formula against breast cancer. The impressive results are found in the most recent publication of Integrative Cancer Therapies.

25 Oct 2010

Researchers identify chain reaction of brain activity that controls sequential actions

As anyone who as ever picked up a guitar or a tennis racket knows, precise timing is often an essential part of performing complex tasks. Now, by studying the brain circuits that control bird song, MIT researchers have identified a "chain reaction" of brain activity that appears to control the timing of song.

25 Oct 2010

CARTaGENE database meets 20k participant milestone

This week, the last questionnaire was filled out and the final vial of blood was drawn, closing CARTaGENE's first ambitious goal of collecting samples and data from 20 000 Quebecers.

25 Oct 2010

HRSA supports Sickle Cell Disease Treatment Demonstration Program with $1.6M award

HRSA has awarded $1.6 million to support the Sickle Cell Disease Treatment Demonstration Program (SCDTDP). The program is designed to establish practice models for the prevention and treatment of sickle cell disease through the coordinated efforts of providers, key stake holders, affected individuals and their families.

25 Oct 2010

New synthetic population can help computational modelers to study infectious diseases

To help computational modelers who study the spread of infectious diseases, including flu, researchers supported by the National Institutes of Health at RTI International in North Carolina created a synthetic population mirroring U.S. demographics. Now they've added another layer of realism: where the virtual citizens live.

25 Oct 2010

FlexBone shows potential replacement for current bone transplantations

With a failure rate as high as 50 percent, bone tissue grafts pose a significant obstacle to orthopedic surgeons attempting to repair complex fractures or large areas of bone loss, such as those often caused by trauma and cancer. Current synthetic substitutes rarely possess the bone-like properties needed for successful grafting and are often difficult for surgeons to manipulate in the operating room. In response to these challenges, researchers at UMass Medical School have developed an easy-to-produce, inexpensive, synthetic bone material called FlexBone.

25 Oct 2010

Research News and Research

Soligenix reports Phase 2 clinical trial results of orBec for GVHD

DATATRAK announces 2010 Q4 release of eClinical solution

Competition for agricultural land contributes to hunger of 500M small-scale farmers, U.N. official says

Barriers for female heart patients entering cardiac rehab

Cryo-Cell to launch new reproductive tissue service for cryopreserved embryos, oocyctes

First Edition: October 25, 2010

Non communicable diseases will cost India USD237 billion during 2006-15

Popular Mechanics recognizes three NSF-funded projects with innovation Breakthrough Awards

New report highlights numerous monoclonal antibodies for treating digestive system cancers

Childhood allergies and asthma linked to development in the womb

New Canadian Cardiovascular Society guidelines support clinicians in practicing evidence-based medicine

Antigenics expands HSPPC-96 Phase 2 clinical study in glioma

Neptune launches Onemia medical food

Diabetics living in adverse neighborhood conditions more likely to develop lower body functional limitations

Researchers publish effects of doctor-designed formula against breast cancer

Researchers identify chain reaction of brain activity that controls sequential actions

CARTaGENE database meets 20k participant milestone

HRSA supports Sickle Cell Disease Treatment Demonstration Program with $1.6M award

New synthetic population can help computational modelers to study infectious diseases

FlexBone shows potential replacement for current bone transplantations

A new way of characterising biomolecules eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News